1. Biomarkers-definitions-working group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69(3):89–95.
2. Füzéry AK, Levin J, Chan MM, et al. Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges. Clin Proteomics. 2013;10(1):13.
3. Chan DW, Schwartz MK. Tumor markers. In: Diamandis EP, Fritsche HA, Lilja H, Chan DW, Schwartz MK, editors. Physiology, pathobiology, technology, and clinical applications. Tumor markers: introduction and general principles. Washington, DC: AACC Press; 2002. p. 9–17.
4. Italiano A. Prognostic or predictive? It’s time to get back to definitions. J Clin Oncol. 2011;38(35):4718.
5. Oldenhuis CN, Oosting SF, Gietema JA, et al. Prognostic versus predictive value of biomarkers in oncology. Eur J Cancer. 2008;44(7):946–53.